Intriguingly, the homozygous deletion of TCAB1, a factor essential to telomerase trafficking, assembling, and function, occurred in 11.7% of PRAD, 6.9% LIHC, and 6.6% SARC tumors (Fig. 5B). Here, WRAP53 is linked to prostate adenocarcinoma.